Laryngeal Diseases Clinical Trial
Official title:
Double-blind Placebo Controlled Trial of the Treatment of Chronic Laryngitis With Amitryptiline
The study will compare the effectiveness of amitriptyline versus placebo (inactive medication) in treating chronic laryngitis. At the baseline visit, subjects will be assigned at random to amitriptyline or placebo which they will take for 8 weeks. Subjects will be seen in the clinic at baseline and at 8 weeks. Improvement will be measured using standardized symptom scales, and a self-reported subjective improvement percentage.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01276418 -
ENT FiberLase CO2 Study
|
N/A | |
Recruiting |
NCT04575142 -
Comparison of Office-based KTP and CO2 Laser Outcomes in Patients With Vocal Cord Lesions.
|
N/A | |
Completed |
NCT02960243 -
Deep Brain Stimulation for Voice Tremor: Left, Right, or Both Hemispheres?
|
N/A | |
Terminated |
NCT02552225 -
Treatment of Chronic Laryngitis With Amitriptyline
|
Phase 2/Phase 3 |